Management of aspergillosis in immunocompromised patients. Recommendations of Lille University Hospital - 4th version - November 2004;Prise en charge diagnostique et thérapeutique des infections à Aspergillus sp. chez le patient immunodéprimé. Recommandations du CHRU de Lille - Version 4 - Novembre 2004

Medecine et Maladies Infectieuses

Volumn 35, Issue 3, 2005, Pages 121-134

  Alfandari, S ^a   Leroy, O ^a   De Botton, S ^b   Yakoub Agha, I ^b   Durand Joly, I ^b   Leroy Cotteau, A ^b   Beaucaire, G ^b  

^a CENTRE HOSPITALIER DE TOURCOING   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Antifungal agents; Aspergillosis; Chest CT scan; Combination therapy

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; CISPLATIN; CORTICOSTEROID; CYCLOSPORIN; FLUCONAZOLE; FOSCARNET; GALACTOMANNAN; GLYCOPEPTIDE; ITRACONAZOLE; NEOMYCIN; PENTAMIDINE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; VORICONAZOLE;

ANTIBIOTIC PROPHYLAXIS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG FORMULATION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; LUNG ASPERGILLOSIS; LUNG LAVAGE; NEPHROTOXICITY; NONHUMAN; PRACTICE GUIDELINE; REVIEW; STEM CELL TRANSPLANTATION; UNIVERSITY HOSPITAL;

EID: 19544388964     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medmal.2005.01.004     Document Type: Article

References (88)

1. Prise en charge des candidoses et aspergilloses invasives de l'adulte. Conf́rence de Consensus commune organiśe conjointement par la SFAR, la SPILF et la SRLF. Texte long Med Mal Infect 35 2005 48
2. B. Mehrad, G. Paciocco, and F.J. Martinez Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature Chest 119 2001 169 175
3. N. Singh Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices Clin Infect Dis 33 2001 1692 1696
4. D.W. Denning Invasive aspergillosis Clin Infect Dis 26 1998 781 803
5. D.A. Stevens, V.L. Kan, and M.A. Judson Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America Clin Infect Dis 30 2000 696 709
6. J. Fortun, P. Martin-Davila, and M.E. Alvarez Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients Transplantation 71 2001 145 149
7. W.B. Grow, J.S. Moreb, and D. Roque Late onset of invasive Aspergillus infection in bone marrow transplant patients at a university hospital Bone Marrow Transplant 29 2002 15 19
8. R.N. Husni, S.M. Gordon, and D.L. Longworth Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients Clin Infect Dis 26 1998 753 755
9. A. Katz, M. Ehrenfeld, and A. Livneh Aspergillosis in systemic lupus erythematosus Semin Arthritis Rheum 26 1996 635 640
10. O. Lortholary, S. Ascioglu, and P. Moreau Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Francais du Myelome Clin Infect Dis 30 2000 41 46
11. A. Moreno, M. Perez-Elias, and J. Casado Role of antiretroviral therapy in long-term survival of patients with AIDS-related pulmonary aspergillosis Eur J Clin Microbiol Infect Dis 19 2000 688 693
12. E. Ninin, N. Milpied, and P. Moreau Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants Clin Infect Dis 33 2001 41 47
13. A. Nosari, P. Oreste, and R. Cairoli Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion Am J Hematol 68 2001 231 236
14. D.L. Paterson, and N. Singh Invasive aspergillosis in transplant recipients Medicine (Baltimore) 78 1999 123 138
15. J.E. Patterson, J. Peters, and J.H. Calhoon Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients Transpl Infect Dis 2 2000 22 28
16. P. Ribaud, C. Chastang, and J.P. Latge Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation Clin Infect Dis 28 1999 322 330
17. N. Singh, L. Mieles, and V.L. Yu Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B Clin Infect Dis 17 1993 906 908
18. R. Utili, R. Zampino, and F. De Vivo Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment Clin Transplant 14 2000 282 286
19. R.P. Woitas, J.K. Rockstroh, and A. Theisen Changing role of invasive aspergillosis in AIDS - a case control study J Infect 37 1998 116 122
20. N. Ohmagari, I.I. Raad, and R. Hachem Invasive aspergillosis in patients with solid tumors Cancer 101 2004 2300 2302
21. A.H. Groll, M. Kurz, and W. Schneider Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival Mycoses 42 1999 431 442
22. D.W. Denning Therapeutic outcome in invasive aspergillosis Clin Infect Dis 23 1996 608 615
23. S.J. Lin, J. Schranz, and S.M. Teutsch Aspergillosis case-fatality rate: systematic review of the literature Clin Infect Dis 32 2001 358 366
24. S. Ascioglu, J.H. Rex, and B. De Pauw Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus Clin Infect Dis 34 2002 7 14
25. Socít́ Francaise d'Hygìne Hospitalìre. Pŕvention du risque aspergillaire chez l'immunod́priḿ. Texte Long Hygienes 8 2000 316 327
26. A. Sulahian, S. Touratier, and P. Ribaud False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam N Engl J Med 349 2003 2366 2367
27. C. Viscoli, M. Machetti, and P. Cappellano False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam Clin Infect Dis 38 2004 913 916
28. T.J. Walsh, S. Shoham, and R. Petraitiene Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction J Clin Microbiol 42 2004 4744 4748
29. D. Buchheidt, C. Baust, and H. Skladny Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results Clin Infect Dis 33 2001 428 435
30. D. Buchheidt, M. Hummel, and D. Schleiermacher Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients Br J Haematol 125 2004 196 202
31. M. Kami, T. Fukui, and S. Ogawa Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis Clin Infect Dis 33 2001 1504 1512
32. M. Kawazu, Y. Kanda, and Y. Nannya Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1 - >3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders J Clin Microbiol 42 2004 2733 2741
33. C. Lass-Florl, E. Gunsilius, and G. Gastl Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples J Clin Microbiol 42 2004 4154 4157
34. D. Caillot, A. Bernard, and J.F. Couaillier Strat́gies diagnostique et th́rapeutique dans les aspergilloses pulmonaires invasives des patients atteints d'h́mopathies malignes Med Mal Infect 28 1998 474 484
35. M. Kami, Y. Tanaka, and Y. Kanda Computed tomographic scan of the chest, latex agglutination test and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients Haematologica 85 2000 745 752
36. D. Caillot, L. Mannone, and B. Cuisenier Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients Clin Microbiol Infect 7 Suppl 2 2001 54 61
37. D. Caillot, J.F. Couaillier, and A. Bernard Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia J Clin Oncol 19 2001 253 259
38. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients MMWR Recomm Rep 49 2000 1 7
39. P.C. Gotzsche, and H.K. Johansen Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia Br Med J 314 1997 1238 1244
40. S. Schwartz, G. Behre, and V. Heinemann Aerosolized amphotericin B inhalations as prophylaxis of invasive Aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial Blood 93 1999 3654 3661
41. G.R. Morgenstern, A.G. Prentice, and H.G. Prentice A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group Br J Haematol 105 1999 901 911
42. e ICAAC 2001
43. F. Offner, C. Cordonnier, and P. Ljungman Impact of previous aspergillosis on the outcome of bone marrow transplantation Clin Infect Dis 26 1998 1098 1103
44. V. Calvo, J.M. Borro, and P. Morales Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group Chest 115 1999 1301 1304
45. J. Hamacher, A. Spiliopoulos, and A.M. Kurt Pre-emptive therapy with azoles in lung transplant patients. Geneva Lung Transplantation Group Eur Respir J 13 1999 180 186
46. J. Tollemar, K. Hockerstedt, and B.G. Ericzon Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study Transplantation 59 1995 45 50
47. C.V. Paya Prevention of fungal and hepatitis virus infections in liver transplantation Clin Infect Dis 33 Suppl 1 2001 S47 S52
48. J.H. Rex, T.J. Walsh, and J.D. Sobel Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America Clin Infect Dis 30 2000 662 678
49. R. Herbrecht, S. Neuville, and V. Letscher-Bru Fungal infections in patients with neutropenia: challenges in prophylaxis and treatment Drugs Aging 17 2000 339 351
50. K.A. Marr, K. Seidel, and T.C. White Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole J Infect Dis 181 2000 309 316
51. T.R. Rocco, S.E. Reinert, and H.H. Simms Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance Arch Surg 135 2000 160 165
52. J.D. Cartledge, J. Midgley, and B.G. Gazzard Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis AIDS 11 1997 1839 1844
53. M. Goldman, G.A. Cloud, and M. Smedema Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses study group Antimicrob Agents Chemother 44 2000 1585 1587
54. W.T. Hughes, D. Armstrong, and G.P. Bodey 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 34 2002 730 751
55. H.G. Prentice, I.M. Hann, and R. Herbrecht A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients Br J Haematol 98 1997 711 718
56. T.J. Walsh, R.W. Finberg, and C. Arndt Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group N Engl J Med 340 1999 764 771
57. J.R. Wingard, M.H. White, and E. Anaissie A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group Clin Infect Dis 31 2000 1155 1163
58. M.H. White, R.A. Bowden, and E.S. Sandler Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia Clin Infect Dis 27 1998 296 302
59. R.V. Fleming, H.M. Kantarjian, and R. Husni Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia Leuk Lymphoma 40 2001 511 520
60. D.J. Winston, J.W. Hathorn, and M.G. Schuster A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer Am J Med 108 2000 282 289
61. M. Boogaerts, D.J. Winston, and E.J. Bow Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial Ann Intern Med 135 2001 412 422
62. T.J. Walsh, P. Pappas, and D.J. Winston Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever N Engl J Med 346 2002 225 234
63. T.J. Walsh, H. Teppler, and G.R. Donowitz Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia N Engl J Med 351 2004 1391 1402
64. A.C. Leenders, S. Daenen, and R.L. Jansen Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections Br J Haematol 103 1998 205 212
65. M. Ellis, D. Spence, and B. De Pauw An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis Clin Infect Dis 27 1998 1406 1412
66. T.J. Walsh, J.L. Goodman, and P. Pappas Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study Antimicrob Agents Chemother 45 2001 3487 3496
67. R. Bowden, P. Chandrasekar, and M.H. White A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients Clin Infect Dis 35 2002 359 366
68. F. Offner, V. Krcmery, and M. Boogaerts Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B Antimicrob Agents Chemother 48 2004 4808 4812
69. J.W. Van't Wout, I. Novakova, and C.A. Verhagen The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B J Infect 22 1991 45 52
70. D. Caillot, H. Bassaris, and A. McGeer Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS Clin Infect Dis 33 2001 e83 e90
71. D.W. Denning, P. Ribaud, and N. Milpied Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis Clin Infect Dis 34 2002 563 571
72. R. Herbrecht, D.W. Denning, and T.F. Patterson Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med 347 2002 408 415
73. J. Maertens, I. Raad, and G. petrikkos Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy Clin Infect Dis 39 2004 1563 1571
74. S. Arikan, M. Lozano-Chiu, and V. Paetznick In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp Antimicrob Agents Chemother 46 2002 245 247
75. e ICAAC 2001 [abstract j-125]
76. e ICAAC 2002 [abstract M-1818]
77. e ICAAC 2002 [abstract M-859]
78. e ICAAC 2002 Combination Antifungals for Treatment of Pulmonary Invasive Aspergillosis [abstract M-860]
79. e ICAAC 2002 [abstract M-1820]
80. V. Ratanatharathorn, P. Flynn, and J.A. van Burik Micafungin in Combination with Systemic Antifungal Agents in the Treatment of Refractory Aspergillosis (RA) in Bone Marrow Transplant (BMT) Patients 44th ASH 2002 [abstract 2472]
81. L.R. Lum, T.F. Turco, and J. Leone Combination therapy with caspofungin and amphotericin B lipid complex Am J Health Syst Pharm 59 2002 80 81
82. M.A. Rubin, K.C. Carroll, and B.C. Cahill Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans Clin Infect Dis 34 2002 1160 1161
83. D.P. Kontoyiannis, R. Hachem, and R.E. Lewis Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies Cancer 98 2003 292 299
84. K.A. Marr, M. Boeckh, and R.A. Carter Combination antifungal therapy for invasive aspergillosis Clin Infect Dis 39 2004 797 802
85. T. Yeghen, C.C. Kibbler, and H.G. Prentice Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution Clin Infect Dis 31 2000 859 868
86. A. Bernard, D. Caillot, and J.F. Couaillier Surgical management of invasive pulmonary aspergillosis in neutropenic patients Ann Thorac Surg 64 1997 1441 1447
87. G.T. Siwek, K.J. Dodgson, and M. Magalhaes-Silverman Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis Clin Infect Dis 39 2004 584 587
88. e ICAAC 2004 [abstract M-665]